Hirotaka Matsui

11PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersHaematologyMedical microbiology not elsewhere classifiedMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 28, 2025
Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan.

Hirotaka Matsui, Jun Takizawa, Kensuke Kojima

|Mar 16, 2024
Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines.

Hirotaka Matsui, Makoto Hirata

|Jan 11, 2024
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.

Hironori Arai, Hirotaka Matsui, SungGi Chi

|Dec 13, 2023
Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.

Akira Nishimura, Kazuaki Yokoyama, Takuya Naruto

|Apr 18, 2023
Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs.

Takako Yokomizo-Nakano, Ai Hamashima, Sho Kubota

|Feb 13, 2023
Ribosome profiling analysis reveals the roles of DDX41 in translational regulation.

Saruul Tungalag, Satoru Shinriki, Mayumi Hirayama

Pageof 2

Frequent Collaborators

3 joint publications

Akinori Kanai

2 joint publications

Satoru Shinriki

1 joint publications

Hideki Nakayama

1 joint publications

Akihiko Yokoyama